Channelpedia

PubMed 15726306


Referenced in Channelpedia wiki pages of: none

Automatically associated channels: Cav1.1



Title: Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family.

Authors: Qiufen Wang, Mugen Liu, Chunsheng Xu, Zhaohui Tang, Yuhua Liao, Rong Du, Wei Li, Xiaoyan Wu, Xu Wang, Ping Liu, Xianqin Zhang, Jianfang Zhu, Xiang Ren, Tie Ke, Qing Wang, Junguo Yang

Journal, date & volume: J. Mol. Med., 2005 Mar , 83, 203-8

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/15726306


Abstract
Hypokalemic periodic paralysis (HypoPP) is an autosomal dominant disorder which is characterized by periodic attacks of muscle weakness associated with a decrease in the serum potassium level. The skeletal muscle calcium channel alpha-subunit gene CACNA1S is a major disease-causing gene for HypoPP, however, only three specific HypoPP-causing mutations, Arg528His, Arg1,239His and Arg1,239Gly, have been identified in CACNA1S to date. In this study, we studied a four-generation Chinese family with HypoPP with 43 living members and 19 affected individuals. Linkage analysis showed that the causative mutation in the family is linked to the CACNA1S gene with a LOD score of 6.7. DNA sequence analysis revealed a heterozygous C to G transition at nucleotide 1,582, resulting in a novel 1,582C-->G (Arg528Gly) mutation. The Arg528Gly mutation co-segregated with all affected individuals in the family, and was not present in 200 matched normal controls. The penetrance of the Arg528Gly mutation was complete in male mutation carriers, however, a reduced penetrance of 83% (10/12) was observed in female carriers. No differences were detected for age-at-onset and severity of the disease (frequency of symptomatic attacks per year) between male and female patients. Oral intake of KCl is effective in blocking the symptomatic attacks. This study identifies a novel Arg528Gly mutation in the CACNA1S gene that causes HypoPP in a Chinese family, expands the spectrum of mutations causing HypoPP, and demonstrates a gender difference in the penetrance of the disease.